GoodRx Holdings Inc.

38.20+0.0600+0.16%Vol 1.51M1Y Perf -24.71%
Apr 19th, 2021 16:00 DELAYED
BID38.21 ASK38.91
Open38.02 Previous Close38.14
Pre-Market- After-Market-
 - -  - -%
Target Price
52.58 
Analyst Rating
— — 0.00
Potential %
37.64 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★+     49.54
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★     54.10
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap14.98B 
Earnings Rating
Price Range Ratio 52W %
15.60 
Earnings Date
10th Jun 2021

Today's Price Range

37.2638.29

52W Range

33.3964.22

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-2.05%
1 Month
2.39%
3 Months
-8.83%
6 Months
-22.12%
1 Year
-24.71%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
GDRX38.200.06000.16
AAPL134.840.68000.51
GOOG2 302.404.64000.20
MSFT258.74-2.0000-0.77
XOM56.48-0.1800-0.32
WFC43.880.04000.09
JNJ162.690.45000.28
FB302.24-3.9400-1.29
GE13.460.07000.52
JPM152.65-0.6500-0.42
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.50-0.60-20.00
Q03 2020-0.03-0.25-733.33
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date10th Jun 2021
Estimated EPS Next Report-
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume1.51M
Shares Outstanding392.13M
Trades Count14.88K
Dollar Volume89.58M
Avg. Volume2.18M
Avg. Weekly Volume1.45M
Avg. Monthly Volume2.52M
Avg. Quarterly Volume2.27M

GoodRx Holdings Inc. (NASDAQ: GDRX) stock closed at 38.2 per share at the end of the most recent trading day (a 0.16% change compared to the prior day closing price) with a volume of 1.51M shares and market capitalization of 14.98B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 338 people. GoodRx Holdings Inc. CEO is Douglas Hirsch / Trevor Bezdek.

The one-year performance of GoodRx Holdings Inc. stock is -24.71%, while year-to-date (YTD) performance is -5.3%. GDRX stock has a five-year performance of %. Its 52-week range is between 33.39 and 64.22, which gives GDRX stock a 52-week price range ratio of 15.60%

GoodRx Holdings Inc. currently has a PE ratio of -35.60, a price-to-book (PB) ratio of 21.02, a price-to-sale (PS) ratio of 4.41, a price to cashflow ratio of 79.80, a PEG ratio of 2.32, a ROA of -31.62%, a ROC of 3.43% and a ROE of 156.09%. The company’s profit margin is -53.32%, its EBITDA margin is 13.70%, and its revenue ttm is $550.70 Million , which makes it $8.67 revenue per share.

Of the last four earnings reports from GoodRx Holdings Inc., there were 0 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. GoodRx Holdings Inc.’s next earnings report date is 10th Jun 2021.

The consensus rating of Wall Street analysts for GoodRx Holdings Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for GoodRx Holdings Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

GoodRx Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

GoodRx Holdings Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 21.95, ATR14 : 2.93, CCI20 : -29.84, Chaikin Money Flow : 0.03, MACD : -3.00, Money Flow Index : 57.60, ROC : -2.10, RSI : 35.63, STOCH (14,3) : 34.05, STOCH RSI : 0.37, UO : 44.37, Williams %R : -65.95), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of GoodRx Holdings Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

GoodRx Holdings Inc.

GoodRx Holdings Inc provides digital healthcare platform that provides prescription drugs at affordable prices. The company offers services like diabetes testing, general visits, blood tests, HIV testing, Vitamin D screening, Pregnancy testing, and many more.

CEO: Douglas Hirsch / Trevor Bezdek

Telephone: +1 855 268-2822

Address: 233 Wilshire Boulevard, Santa Monica 90401, CA, US

Number of employees: 338

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

43%57%

Bearish Bullish

33%67%

Bearish Bullish

67%33%

News

Stocktwits